TOSITUMOMAB Side Effects

7010343-3 | Myelodysplastic Syndrome
on Sep 15, 2010 Male patient from UNITED STATES , 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: myelodysplastic syndrome. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), RITUXAN (View Rituxan Review and Rituxan Label ).

6993013-7 | Prostate Cancer
Patient was taking Tositumomab (View Usage). Patient had the following side effects: prostate cancer (What is prostate cancer?) on Sep 16, 2010 from UNITED STATES Additional patient health information: Male patient , 74 years of age, weighting 165.3 lb, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ).

6985462-8 | Sebaceous Carcinoma
Adverse event was reported on Sep 13, 2010 by a Male patient taking Tositumomab (View Usage) (Dosage: 450mg Single Dose) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED KINGDOM , weighting 202.8 lb, After Tositumomab was administered, patient had the following side effects: sebaceous carcinoma. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

6980861-2 | Prostate Cancer
on Sep 08, 2010 Male patient from UNITED STATES , 74 years of age, weighting 165.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: prostate cancer (What is prostate cancer?). Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ).


6786848-7 | Haemoglobin Decreased, Leukopenia, Thrombocytopenia
on Jun 17, 2010 Female patient from UNITED STATES , 56 years of age, weighting 125.7 lb, was diagnosed with diffuse large b-cell lymphoma and was treated with Tositumomab (View Usage). Patient had the following side effects: haemoglobin decreased, leukopenia, thrombocytopenia. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ).

6732882-2 | Dysphagia, Mucosal Inflammation
Patient was taking Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: dysphagia, mucosal inflammation on May 12, 2010 from UNITED STATES Additional patient health information: Male patient , 57 years of age, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), VP 16 (60mgk Single Dose) (View Vp-16 Review and Vp-16 Label ), CYCLOPHOSPHAMIDE (100mgk Single Dose) (View Cyclophosphamide Review and Cyclophosphamide Label ), STEM CELL TRANSPLANT (View Stem Cell Transplant Review and Stem Cell Transplant Label ). Patient was hospitalized.

6732881-0 | Atelectasis, Diarrhoea, Febrile Neutropenia, Oral Mucosal Exfoliation, Pleural Effusion, Rash, Stomatitis, Tongue Exfoliation
Adverse event was reported on May 12, 2010 by a Female patient taking Tositumomab (View Usage) (Dosage: 450mg Single Dose) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 54 years of age, Patient experienced the following unwanted or unexpected effects: atelectasis, diarrhoea, febrile neutropenia, oral mucosal exfoliation, pleural effusion, rash (What is rash?), stomatitis, tongue exfoliation. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), VP 16 (View Vp-16 Review and Vp-16 Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), STEM CELL TRANSPLANT (View Stem Cell Transplant Review and Stem Cell Transplant Label ). Patient was hospitalized.

6684981-1 | Cellulitis
on Apr 09, 2010 Female patient from UNITED STATES , 48 years of age, weighting 179.9 lb, was treated with Tositumomab (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?). Tositumomab dosage: . During the same period patient was treated with VELCADE (View Velcade Review and Velcade Label ). Patient was hospitalized.

6641318-1 | Myelodysplastic Syndrome
on Mar 10, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: myelodysplastic syndrome. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with DECITABINE (View Decitabine Review and Decitabine Label ).

6630189-5 | Renal Cell Carcinoma
Patient was taking Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: renal cell carcinoma on Mar 03, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (35mg Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ).

6360278-4 | Haemophilus Infection, Respiratory Tract Infection
Adverse event was reported on Sep 09, 2009 by a Male patient taking Tositumomab (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED KINGDOM , weighting 240.7 lb, Patient had the following side effects: haemophilus infection, respiratory tract infection. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

6307790-1 | Renal Cell Carcinoma
on Jul 31, 2009 Male patient from UNITED STATES , 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: renal cell carcinoma. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (35mg Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ).

6153124-5 | Hiccups, Injury, Metastases To Meninges, Subdural Haematoma, Thrombocytopenia
on Apr 04, 2009 Male patient from UNITED STATES , 81 years of age, weighting 249.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: hiccups, injury, metastases to meninges, subdural haematoma, thrombocytopenia. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

6105901-4 | Lip And/or Oral Cavity Cancer
Patient was taking Tositumomab (View Usage). Patient had the following side effects: lip and/or oral cavity cancer on Feb 27, 2009 from UNITED STATES Additional patient health information: Male patient , 48 years of age, weighting 164.9 lb, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ).

5913817-9 | Myelodysplastic Syndrome
Adverse event was reported on Sep 23, 2008 by a Female patient taking Tositumomab (View Usage) (Dosage: 450mg Single Dose) was diagnosed with non-hodgkin's lymphoma and. Location: CANADA , 67 years of age, After Tositumomab was administered, patient had the following side effects: myelodysplastic syndrome. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CHLORAMBUCIL (View Chlorambucil Review and Chlorambucil Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5888362-X | Dehydration
on Sep 15, 2008 Female patient from UNITED STATES , 53 years of age, weighting 167.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LASIX (View Lasix Review and Lasix Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

5873384-5 | Laryngeal Cancer
on Aug 29, 2008 Male patient from UNITED STATES , 74 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient had the following side effects: laryngeal cancer. Tositumomab dosage: .

5845139-9 | Pyrexia, Radiculitis Brachial
Patient was taking Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: pyrexia, radiculitis brachial on Jul 31, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 53 years of age, weighting 181.2 lb, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

5804567-8 | Adrenal Insufficiency, Anaemia, Atrial Fibrillation, Atrial Flutter, Blood Albumin Decreased, Bone Marrow Failure, Convulsion, Decreased Appetite, Dehydration
Adverse event was reported on Jul 07, 2008 by a Female patient taking Tositumomab (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 64 years of age, weighting 168.2 lb, Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, anaemia, atrial fibrillation (What is atrial fibrillation?), atrial flutter, blood albumin decreased, bone marrow failure, convulsion, decreased appetite, dehydration. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), PREMARIN (View Premarin Review and Premarin Label ), INDERAL (View Inderal Review and Inderal Label ), TYLENOL W/ CODEINE (View Tylenol W/ Codeine Review and Tylenol W/ Codeine Label ), ZOFRAN (View Zofran Review and Zofran Label ), ATIVAN (View Ativan Review and Ativan Label ). Patient was hospitalized.

5692336-1 | Anaemia, Cardiac Failure Congestive, Pancytopenia, Pneumonia
on Mar 27, 2008 Male patient from UNITED STATES , 66 years of age, weighting 198.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient had the following side effects: anaemia, cardiac failure congestive, pancytopenia, pneumonia (What is pneumonia?). Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

5679280-0 | Cardiomyopathy, Chest Pain, Dyspnoea
on Mar 19, 2008 Female patient from UNITED STATES , 53 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), chest pain (What is chest pain?), dyspnoea. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (4.87mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

5513020-0 | Sepsis
Patient was taking Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?) on Nov 08, 2007 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 155.9 lb, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

5499469-3 | Anaemia, Bundle Branch Block, Confusional State, Dehydration, Dyspnoea, Gastrointestinal Haemorrhage, Hallucination, Visual, Hyponatraemia, Malnutrition
Adverse event was reported on Oct 19, 2007 by a Male patient taking Tositumomab (View Usage) (Dosage: 450mg Single Dose) . Location: UNITED STATES , 81 years of age, Patient had the following side effects: anaemia, bundle branch block, confusional state, dehydration, dyspnoea, gastrointestinal haemorrhage, hallucination, visual, hyponatraemia, malnutrition. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5.4mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), ALTACE (View Altace Review and Altace Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AVANDIA (View Avandia Review and Avandia Label ). Patient was hospitalized.

5460669-X | Diarrhoea, Gastritis, Pancytopenia
on Sep 10, 2007 Male patient from UNITED STATES , 43 years of age, weighting 193.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: diarrhoea, gastritis, pancytopenia. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

5447747-6 | Chest Pain, Pericarditis, Pleurisy
on Sep 04, 2007 Male patient from UNITED STATES , 45 years of age, weighting 215.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), pericarditis, pleurisy. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), COUMADIN (View Coumadin Review and Coumadin Label ), POTASSIUM IODIDE (View Potassium Iodide Review and Potassium Iodide Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ). Patient was hospitalized.

5407108-2 | Erythropoiesis Abnormal, Myelodysplastic Syndrome, Thrombocytopenia
Patient was taking Tositumomab (View Usage). Patient had the following side effects: erythropoiesis abnormal, myelodysplastic syndrome, thrombocytopenia on Jul 24, 2007 from UNITED STATES Additional patient health information: Male patient , 50 years of age, . Tositumomab dosage: . During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), RITUXAN (View Rituxan Review and Rituxan Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

5320423-6 | Diffuse Large B-cell Lymphoma, Myelodysplastic Syndrome
Adverse event was reported on Apr 30, 2007 by a Male patient taking Tositumomab (View Usage) (Dosage: 450mg Single Dose) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 59 years of age, weighting 233.7 lb, After Tositumomab was administered, patient had the following side effects: diffuse large b-cell lymphoma, myelodysplastic syndrome. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), SATOLOL (View Satolol Review and Satolol Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

5307492-4 | Disease Progression, Lung Adenocarcinoma
on Apr 16, 2007 Male patient from UNITED STATES , 62 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, lung adenocarcinoma. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ).

5307491-2 | Diarrhoea, Gastritis
on Apr 17, 2007 Male patient from UNITED STATES , 43 years of age, weighting 193.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient had the following side effects: diarrhoea, gastritis. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

5280251-7 | Acute Myeloid Leukaemia, Asthenia, Chills, Ear Pain, Myelodysplastic Syndrome, Pneumonia
Patient was taking Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: acute myeloid leukaemia, asthenia, chills, ear pain, myelodysplastic syndrome, pneumonia (What is pneumonia?) on Mar 21, 2007 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 210.5 lb, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ). Patient was hospitalized.

5237742-4 | Acute Myeloid Leukaemia, Asthenia, Chills, Ear Pain, Myelodysplastic Syndrome, Pneumonia
Adverse event was reported on Feb 07, 2007 by a Male patient taking Tositumomab (View Usage) (Dosage: 450mg Single Dose) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 60 years of age, weighting 210.5 lb, Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, asthenia, chills, ear pain, myelodysplastic syndrome, pneumonia (What is pneumonia?). During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ). Patient was hospitalized.

5165648-8 | Contusion, Disease Progression, Lower Respiratory Tract Infection, Lung Consolidation, Pelvic Venous Thrombosis, Platelet Count Decreased, Pleural Effusion, Pleuritic Pain, Pulmonary Embolism
on Jul 02, 1996 Female patient from UNITED KINGDOM , 60 years of age, weighting 123.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient had the following side effects: contusion, disease progression, lower respiratory tract infection, lung consolidation, pelvic venous thrombosis, platelet count decreased, pleural effusion, pleuritic pain, pulmonary embolism (What is pulmonary embolism?). Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

5161621-4 | Pyrexia, Radiculitis Brachial
on Mar 28, 2000 Female patient from UNITED KINGDOM , 53 years of age, weighting 181.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: pyrexia, radiculitis brachial. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

5161620-2 | Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Fall, Gastric Polyps, Herpes Zoster, Hiccups, Injury, Malignant Neoplasm Progression
Patient was taking Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, fall (What is fall?), gastric polyps, herpes zoster, hiccups, injury, malignant neoplasm progression on Nov 05, 1999 from UNITED STATES Additional patient health information: Male patient , 81 years of age, weighting 249.6 lb, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

5136276-5 | Disease Progression, Lung Adenocarcinoma
Adverse event was reported on Jun 06, 2005 by a Male patient taking Tositumomab (View Usage) (Dosage: 450mg Single Dose) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 62 years of age, Patient had the following side effects: disease progression, lung adenocarcinoma. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ).

5134681-4 | Cerebral Infarction, Malignant Neoplasm Progression, Metastasis, Pleural Effusion, Prostate Cancer
on Jan 26, 2005 Male patient from UNITED STATES , 62 years of age, weighting 193.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: cerebral infarction, malignant neoplasm progression, metastasis, pleural effusion, prostate cancer (What is prostate cancer?). Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ).

5134680-2 | Dyspnoea, Urticaria
on Nov 10, 2000 Female patient from UNITED STATES , 55 years of age, weighting 235.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, urticaria. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), SSKI (View Sski Review and Sski Label ).

5113757-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Biliary Dilatation, Blood Bilirubin Increased, Jaundice, Liver Function Test Abnormal, Ocular Icterus
Patient was taking Tositumomab (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biliary dilatation, blood bilirubin increased, jaundice (What is jaundice?), liver function test abnormal, ocular icterus on Sep 21, 2006 from UNITED STATES Additional patient health information: Male patient , 47 years of age, was diagnosed with diffuse large b-cell lymphoma and. Tositumomab dosage: Iv X 1. Patient was hospitalized.

4913746-3 | Cardiomyopathy, Chest Pain, Dyspnoea
Adverse event was reported on Dec 13, 2005 by a Female patient taking Tositumomab (View Usage) (Dosage: 450mg Single Dose) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 53 years of age, After Tositumomab was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?), chest pain (What is chest pain?), dyspnoea. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (4.87mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

4868352-6 | Malignant Hepatobiliary Neoplasm
on Dec 06, 2005 Female patient from UNITED STATES , 58 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: malignant hepatobiliary neoplasm. Tositumomab dosage: . During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), CHINESE HERBS (View Chinese Herbs Review and Chinese Herbs Label ).

4865162-0 | Anorexia, Dysphagia, Dyspnoea, Ventricular Dysfunction
on Nov 10, 2005 Female patient from CANADA , 63 years of age, weighting 158.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient had the following side effects: anorexia, dysphagia, dyspnoea, ventricular dysfunction. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5.58mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized and became disabled.

4864196-X | Dyspnoea
Patient was taking Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: dyspnoea on Dec 13, 2005 from UNITED STATES Additional patient health information: Female patient , 53 years of age, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (4.87mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized.

4853224-3 | Malignant Hepatobiliary Neoplasm
Adverse event was reported on Dec 06, 2005 by a Female patient taking Tositumomab (View Usage) (Dosage: ) was diagnosed with non-hodgkin's lymphoma and. Location: UNITED STATES , 58 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: malignant hepatobiliary neoplasm. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), CHINESE HERBS (View Chinese Herbs Review and Chinese Herbs Label ).

4836183-9 | Anorexia, Dysphagia, Dyspnoea, Ejection Fraction Decreased, Pulmonary Hypertension, Ventricular Dysfunction
on Nov 10, 2005 Female patient from CANADA , 63 years of age, weighting 158.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient had the following side effects: anorexia, dysphagia, dyspnoea, ejection fraction decreased, pulmonary hypertension (What is pulmonary hypertension?), ventricular dysfunction. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5.58mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ). Patient was hospitalized and became disabled.

4785600-1 | Asthenia, Dizziness, Dyspnoea, Fatigue, Myelodysplastic Syndrome
on Sep 23, 2005 Male patient from UNITED STATES , 70 years of age, weighting 222.2 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: asthenia, dizziness (What is dizziness?), dyspnoea, fatigue, myelodysplastic syndrome. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5.35mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PENTOSTATIN (View Pentostatin Review and Pentostatin Label ), LASIX (View Lasix Review and Lasix Label ), ZOCOR (View Zocor Review and Zocor Label ), HYZAAR (View Hyzaar Review and Hyzaar Label ).

4772700-5 | Myelodysplastic Syndrome
Patient was taking Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: myelodysplastic syndrome on Sep 12, 2005 from UNITED STATES Additional patient health information: Female patient , 75 years of age, weighting 118.2 lb, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (4.84mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), ARANESP (View Aranesp Review and Aranesp Label ).

4767267-1 | Respiratory Failure
Adverse event was reported on Aug 22, 2005 by a Female patient taking Tositumomab (View Usage) (Dosage: 450mg Single Dose) was diagnosed with deep vein thrombosis (What is deep vein thrombosis?), prophylaxis, seasonal allergy and. Location: CANADA , 58 years of age, Patient had the following side effects: respiratory failure. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), COUMADIN (5mg Per Day) (View Coumadin Review and Coumadin Label ), LASIX (40mg Twice Per Day) (View Lasix Review and Lasix Label ), SPIRONOLACTONE (100mg Per Day) (View Spironolactone Review and Spironolactone Label ), BACTRIM DS (1tab Three Times Per Week) (View Bactrim Ds Review and Bactrim Ds Label ), REACTINE (10mg At Night) (View Reactine Review and Reactine Label ).

4760304-X | Disease Progression, Respiratory Failure
on Aug 22, 2005 Female patient from CANADA , 58 years of age, was diagnosed with b-cell lymphoma, deep vein thrombosis (What is deep vein thrombosis?), oedema peripheral, prophylaxis, seasonal allergy and was treated with Tositumomab (View Usage). After Tositumomab was administered, patient had the following side effects: disease progression, respiratory failure. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), COUMADIN (5mg Per Day) (View Coumadin Review and Coumadin Label ), LASIX (40mg Twice Per Day) (View Lasix Review and Lasix Label ), SPIRONOLACTONE (100mg Per Day) (View Spironolactone Review and Spironolactone Label ), BACTRIM DS (1tab Three Times Per Week) (View Bactrim Ds Review and Bactrim Ds Label ), REACTINE (10mg At Night) (View Reactine Review and Reactine Label ).

4730215-4 | Acute Myeloid Leukaemia, Myelodysplastic Syndrome
on Jul 21, 2005 Male patient from UNITED STATES , 70 years of age, weighting 201.1 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Tositumomab (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, myelodysplastic syndrome. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5.38mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ), RITUXAN (View Rituxan Review and Rituxan Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), FLUDARA (View Fludara Review and Fludara Label ).

4687996-8 | Lung Adenocarcinoma
Patient was taking Tositumomab (View Usage). Patient had the following side effects: lung adenocarcinoma on Jun 06, 2005 from Additional patient health information: Male patient , 62 years of age, was diagnosed with non-hodgkin's lymphoma and. Tositumomab dosage: 450mg Single Dose. During the same period patient was treated with IODINE I 131 TOSITUMOMAB (5mci Single Dose) (View Iodine I 131 Tositumomab Review and Iodine I 131 Tositumomab Label ).